<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study evaluated whether IgG anticardiolipin antibody (aCL) titre and traditional risk factors for <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> bore any relationship to the intima media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) of carotid arteries of patients with idiopathic <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> was assessed by high-resolution sonography at the common carotid, carotid bifurcation and internal carotid in 42 (13 male, 29 female, mean age 31+/-10 years) aPL subjects, 29 with primary thrombotic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and 13 with persistence of aPL in the absence of any underlying disorder </plain></SENT>
<SENT sid="2" pm="."><plain>In the same subjects the following were measured: plasma fibrinogen (FNG), <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor (vWF), plasminogen activator inhibitor (PAI), <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (HC), total cholesterol (<z:chebi fb="0" ids="29327">CHO</z:chebi>), <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (TG), high density and <z:chebi fb="2" ids="39026">low density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi> and <z:chebi fb="15" ids="39026">LDL</z:chebi>), platelet numbers and aCL of IgG and IgM isotype </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> of the internal carotid was greater in males than females (0.48+/-0.03 vs 0.39+/-0.01 mm, P=0.02) </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> of the carotid bifurcation was greater in thrombotic than nonthrombotic subjects (0.50+/-0.02 vs 0.42+/-0.02 mm, P=0.04) </plain></SENT>
<SENT sid="5" pm="."><plain>By simple regression, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> of the common carotids correlated with age (P&lt; 0.0001) IgG aCL titre (P=0.001), FNG (P=0.006), <z:chebi fb="15" ids="39026">LDL</z:chebi> (0.01), <z:chebi fb="0" ids="29327">CHO</z:chebi> (0.02) and PAI (P=0.02) </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> of the carotid bifurcation correlated with age (P=0.002), IgG aCL titre (P=0.0002), FNG (P=0.0001), HC (P=0.009), <z:chebi fb="0" ids="29327">CHO</z:chebi> (P=0.02), vWF (P=0.01) and number of thrombotic events (P=0.03) </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> of the internal carotids correlated with age (P=0.002), IgG aCL titre (P=0.0001), FNG (P=0.0008), PAI (P=0.002) and HC (P=0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>By stepwise multiple regression analysis, IgG aCL titre independently predicted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> at <z:hpo ids='HP_0000001'>all</z:hpo> carotid segments examined (P always &lt;0.005) </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, plasma FNG and HC also resulted independent predictors of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> at the carotid bifurcation (P=0.001 and P&lt;0.0001, respectively) and internal carotid (P=0.03 and P&lt;0.0001, respectively) </plain></SENT>
<SENT sid="10" pm="."><plain>These data strongly support an atherogenic role for IgG aCL in patients with aPL </plain></SENT>
<SENT sid="11" pm="."><plain>Measurement of plasma HC and FNG may help define aPL subjects at higher vascular risk who may require lowering of HC and FNG by vitamin and/or pharmacologic intervention </plain></SENT>
</text></document>